SCHEMBL9670955

SCHEMBL9670955

Cc1cccc2cc([C]=O)ccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.57
CYP2A6 P11509 4/20 0.48
ALDH1A1 P00352 3/20 0.48
HPGD P15428 2/20 0.43
HSD17B10 Q99714 2/20 0.43
CYP1A1 P04798 1/20 0.41
CYP1B1 Q16678 1/20 0.41
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
HSD17B1 P14061 1/20 0.35
HSD17B2 P37059 1/20 0.35
SLC6A4 P31645 2/20 0.33
GRM5 P41594 1/20 0.33
SLC6A2 P23975 1/20 0.32
SLC6A3 Q01959 1/20 0.32
PDE3B Q13370 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16288876 0.81 CYP1A2 (0.57) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL16289082 0.81 CYP1A2 (0.57) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL9478531 0.78 CA1 (0.38) CYP1A2ALDH1A1CYP1A1CYP1B1CA1
SCHEMBL16289542 0.78 CYP1A2 (0.53) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL5406341 0.77 CYP1A2 (0.48) CYP1A2CYP2A6ALDH1A1CYP1A1CYP1B1
SCHEMBL9098177 0.77 PLAU (0.53) CYP1A2HSD17B1HSD17B2
SCHEMBL5385208 0.77 SLC9A1 (0.44) CYP1A2ALDH1A1CYP1A1CYP1B1CA1
SCHEMBL1920437 0.76 CYP1A2 (0.61) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL31484861 0.76 CYP1A2 (0.78) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL28828757 0.76 CYP1A2 (0.78) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 US disclosed
EP-0180188-B1 A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed